Design a site like this with
Get started

Notes on Teleconference with FSA, 1st February 2019


Peter Reynolds, Cannabis Professionals (CannaPro)

Alison Asquith, FSA

Colin Clifford, FSA

Paul Tossell FSA

1. FSA advised that the industry has “one last chance” to submit evidence of significant consumption of CBD extracts within EU area prior to 1997.

2. CannaPro requested clarification as to which authority stipulates this deadline and how long the industry has to respond.

3. FSA advised that it has set the deadline and evidence must be submitted within one month.

4. FSA further clarified that this action was initiated by the EU Novel Foods Working Group.

5. CannaPro took a robust position that one month was unreasonable and suggested three months.

6. FSA will confirm early next week whether three months is acceptable. There was a suggestion that, if so, an interim submission would be required within a month.

7. CannaPro clarified that the products in question could more accurately be described as whole plant low-THC cannabis extracts.

8. CannaPro requested clarification on differing compositions of extracts, eg, CBD concentrations from 2% to 40%.

9. FSA stated that evidence must be for a broad range of compositions. If all evidence is for use of low concentrations of cannabinoids it would not suffice for a 40% product.

10.  CannaPro requested clarification on CO2 extraction.

11. FSA confimed that use of CO2 extraction does NOT make a product novel. If evidence is of products extracted with a different solvent that will be OK. It is the composition that matters, not the extraction method.

12. CannaPro took a robust position throughout that it is unreasonable to turn vague, general discussions about the issue into a short deadline that is an existential threat to the entire industry.

13. FSA responded that it has had substantive discussions with parts of the industry which have been fully engaged and aware of the imperative to provide the evidence.

14. CannaPro understood this to mean the EIHA and CTA. Clearly these bodies cannot in future purport to represent the industry without open communication.


1 thought on “Notes on Teleconference with FSA, 1st February 2019

  1. Paul McMahon

    Jeysus H Christ…It seems every time something good comes along….The EU puts its boot in. I feel the response from vested interests to CBD will be …( via the EU)….Roll out the billions and stop CBD at any and all costs ! No accountability, No responsibility from the EU….AGAIN….Any wonder why people want OUT of this corrupt system. Its seems logical to conclude from the comments and stance of the EU…they have been bought….AGAIN. Who does the buying ? Its usually Big Pharma isn’t it ? They don’t want ordinary Joe to interfere with their profits and because they do have the muscle and billions ($) and power to stop anyone who gets in their way. The EU stance has no logical credibility and yet, because there is no accountability we will all have to fight them tooth and nail. I hope someone, somewhere will/can hold them to account.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: